Jasper Therapeutics, Inc. 471871202 07/03/2025 Advisory vote on approval of the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 545171 0 FOR 545171 FOR Jasper Therapeutics, Inc. 471871202 07/03/2025 Advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 545171 0 ONE YEAR 545171 FOR Immunovant, Inc. 45258J102 08/27/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 221962 0 FOR 221962 FOR Talphera, Inc. 00444T209 10/23/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 316460 0 FOR 316460 FOR Talphera, Inc. 00444T209 10/23/2025 Advisory vote on the preferred frequency of the advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 316460 0 ONE YEAR 316460 FOR Akero Therapeutics, Inc. 00973Y108 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 624526 0 FOR 624526 FOR Merus N.V. N5749R100 12/09/2025 Non-binding advisory proposal to approve certain compensation arrangements SECTION 14A SAY-ON-PAY VOTES ISSUER 366399 0 AGAINST 366399 AGAINST Azenta, Inc. 114340102 01/28/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 546500 0 FOR 546500 FOR Exact Sciences Corporation 30063P105 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the ""Compensation Proposal""). SECTION 14A SAY-ON-PAY VOTES ISSUER 576370 0 AGAINST 576370 AGAINST Amicus Therapeutics, Inc. 03152W109 03/03/2026 To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 550000 0 FOR 550000 FOR Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 401084 0 FOR 401084 FOR Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114800 0 FOR 114800 FOR Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114800 0 ONE YEAR 114800 FOR Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 82000 0 FOR 82000 FOR Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 95600 0 FOR 95600 FOR Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 52280 0 FOR 52280 FOR Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 615 0 FOR 615 FOR Penumbra, Inc. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 120500 0 FOR 120500 FOR Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 37711 0 FOR 37711 FOR Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 172078 0 FOR 172078 FOR Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 172078 0 ONE YEAR 172078 FOR Insmed Incorporated 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 45560 0 FOR 45560 FOR CVS Health Corporation 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 40000 0 FOR 40000 FOR Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1199769 0 FOR 1199769 FOR Travere Therapeutics, Inc. 89422G107 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 101104 0 FOR 101104 FOR Travere Therapeutics, Inc. 89422G107 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 101104 0 ONE YEAR 101104 FOR Viking Therapeutics, Inc. 92686J106 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 6712 0 AGAINST 6712 AGAINST Alkermes plc G01767105 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118752 0 FOR 118752 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 74000 0 FOR 74000 FOR Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 AGAINST 10000 AGAINST Corcept Therapeutics Incorporated 218352102 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 50250 0 FOR 50250 FOR Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 26757 0 FOR 26757 FOR Vera Therapeutics, Inc. 92337R101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 503585 0 FOR 503585 FOR Cytokinetics, Incorporated 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 45364 0 FOR 45364 FOR DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 355600 0 FOR 355600 FOR iRhythm Holdings, Inc. 450056106 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 261750 0 FOR 261750 FOR Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 150450 0 FOR 150450 FOR Tenet Healthcare Corporation 88033G407 05/27/2026 To vote, on an advisory basis, to approve the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 125000 0 FOR 125000 FOR Teva Pharmaceutical Industries Limited 881624209 05/28/2026 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 1545 0 FOR 1545 FOR UnitedHealth Group Incorporated 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 53000 0 FOR 53000 FOR agilon health, inc. 00857U206 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 260000 0 FOR 260000 FOR NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 585538 0 FOR 585538 FOR Oruka Therapeutics, Inc. 687604108 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2043 0 FOR 2043 FOR PTC Therapeutics, Inc. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 81210 0 FOR 81210 FOR Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 763020 0 FOR 763020 FOR Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 763020 0 ONE YEAR 763020 FOR Neurogene Inc. 64135M105 06/03/2026 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 104339 0 FOR 104339 FOR Neurogene Inc. 64135M105 06/03/2026 To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 104339 0 ONE YEAR 104339 FOR Aclaris Therapeutics, Inc. 00461U105 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. SECTION 14A SAY-ON-PAY VOTES ISSUER 4472650 0 FOR 4472650 FOR Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 499764 0 AGAINST 499764 AGAINST Evolent Health, Inc. 30050B101 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 2675000 0 FOR 2675000 FOR Gossamer Bio, Inc. 38341P102 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1254460 0 FOR 1254460 FOR MoonLake Immunotherapeutics 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 61700 0 FOR 61700 FOR Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 202245 0 FOR 202245 FOR Tango Therapeutics, Inc. 87583X109 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 386913 0 FOR 386913 FOR Axsome Therapeutics, Inc. 05464T104 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5500 0 FOR 5500 FOR Dyne Therapeutics, Inc. 26818M108 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 972198 0 FOR 972198 FOR Surgery Partners, Inc. 86881A100 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 204500 0 FOR 204500 FOR Cogent Biosciences, Inc. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 621597 0 FOR 621597 FOR Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 808095 0 FOR 808095 FOR Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 808095 0 ONE YEAR 808095 FOR Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 347666 0 FOR 347666 FOR Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 347666 0 ONE YEAR 347666 FOR Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 350000 0 FOR 350000 FOR Compass Therapeutics, Inc. 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3235008 0 FOR 3235008 FOR Compass Therapeutics, Inc. 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3235008 0 ONE YEAR 3235008 FOR Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 383716 0 AGAINST 383716 AGAINST Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 383716 0 ONE YEAR 383716 FOR Summit Therapeutics Inc. 86627T108 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 231 0 AGAINST 231 AGAINST Arcus Biosciences, Inc. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 180000 0 FOR 180000 FOR BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 12600 0 AGAINST 12600 AGAINST Janux Therapeutics, Inc. 47103J105 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 367009 0 FOR 367009 FOR Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 395 0 FOR 395 FOR Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 701666 109628 FOR 701666 FOR Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 60250 0 FOR 60250 FOR Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (""Say-on-Pay""); SECTION 14A SAY-ON-PAY VOTES ISSUER 2299473 0 FOR 2299473 FOR Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years; SECTION 14A SAY-ON-PAY VOTES ISSUER 2299473 0 ONE YEAR 2299473 FOR Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 170999 0 FOR 170999 FOR Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 170378 0 FOR 170378 FOR Structure Therapeutics Inc. 86366E106 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 640230 0 FOR 640230 FOR Zai Lab Limited 98887Q104 06/17/2026 THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 192678 0 AGAINST 192678 AGAINST Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 799163 0 FOR 799163 FOR EyePoint, Inc. 30233G209 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 258739 0 FOR 258739 FOR Penumbra, Inc. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 108708 0 FOR 108708 FOR Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission (""Say-on-Pay""). SECTION 14A SAY-ON-PAY VOTES ISSUER 1246216 0 FOR 1246216 FOR BridgeBio Pharma, Inc. 10806X102 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 128250 0 FOR 128250 FOR BridgeBio Pharma, Inc. 10806X102 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 128250 0 ONE YEAR 128250 FOR Talphera, Inc. 00444T209 06/22/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3588990 0 FOR 3588990 FOR Kymera Therapeutics, Inc. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 468500 28371 FOR 468500 FOR Phreesia, Inc. 71944F106 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 630399 0 FOR 630399 FOR Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 123836 0 FOR 123836 FOR Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 716270 0 FOR 716270 FOR Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 191175 0 FOR 191175 FOR EDAP TMS SA 268311107 06/26/2026 Non-binding advisory vote to approve the compensation for named executive officers of the Company; SECTION 14A SAY-ON-PAY VOTES ISSUER 1386000 0 FOR 1386000 FOR EDAP TMS SA 268311107 06/26/2026 Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every year; SECTION 14A SAY-ON-PAY VOTES ISSUER 1386000 0 FOR 1386000 FOR EDAP TMS SA 268311107 06/26/2026 Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every two years; SECTION 14A SAY-ON-PAY VOTES ISSUER 1386000 0 AGAINST 1386000 FOR EDAP TMS SA 268311107 06/26/2026 Non-binding advisory vote to hold a non-binding advisory vote on the compensation for the named executive officers of the Company every three years; SECTION 14A SAY-ON-PAY VOTES ISSUER 1386000 0 AGAINST 1386000 FOR